Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet

FDA Drug Profile — GaviLyte-H and Bisacodyl

Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including GaviLyte-H and Bisacodyl. Available dosage form: kit.

Drug details

Generic Name
Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet
Brand Names
GaviLyte-H and Bisacodyl
Application Number
ANDA202217
Sponsor
Lupin Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
KIT
Routes
ORAL

Indications and Usage

1 INDICATIONS & USAGE GaviLyte - H and bisacodyl delayed-release tablet, USP is indicated for cleansing of the colon as a preparation for colonoscopy in adults. GaviLyte - H and bisacodyl delayed-release tablet, USP is a combination of PEG-3350, an osmotic laxative and bisacodyl, a stimulant laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.